Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
162.1 USD | +3.59% | +8.96% | -10.25% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.25% | 16.36B | |
-1.86% | 104B | |
+6.78% | 97.47B | |
+5.71% | 22.25B | |
-12.89% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
+6.51% | 14.39B | |
+35.21% | 12.37B | |
+306.66% | 8.43B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Beigene Insider Sold Shares Worth $8,368,017, According to a Recent SEC Filing